InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by Lian Brian, Chairman & CEO. Director active across 1 companies, notably Viking Therapeutics, Inc.. Cumulatively, 4 filings have been published. The latest transaction was disclosed on 3 January 2022 (Retenue fiscale). Regulator: SEC (Form 4). All data is free.
Declarations4 total
€155,83436,319 shares@ €4.2907100.0% of flow
Common Stock, par value $0.00001 per share
SEC:0001209191-22-001986·
€155,83436,319 shares@ €4.29070.0044% mcap50.0% of flow
Common Stock, par value $0.00001 per share
SEC:0001209191-22-001986:0·
055,500 shares0
Common Stock, par value $0.00001 per share
SEC:0001209191-21-058253·
055,500 shares0
Common Stock, par value $0.00001 per share
SEC:0001209191-21-058253:0·
4 of 4 declarations
About Lian Brian
Brian Lian is the President and Chief Executive Officer of Viking Therapeutics, Inc. He leads the company in its efforts to develop innovative treatments in the healthcare sector. Under his leadership, Viking Therapeutics focuses on research and development of therapeutic solutions that address unmet patient needs. Brian is recognized for his strategic vision and commitment to innovation in the biopharmaceutical industry.
